Alzheimer's Disease Trial, Recruiting NCT06731049 Sponsor: Istanbul University - Cerrahpasa Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT06731049
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Alzheimer's disease by a neurologist, using a specific set of recognised diagnostic guidelines
  • People who are in the early or middle stages of Alzheimer's disease, as measured by a standard assessment tool called the Clinical Dementia Rating Scale
  • People who have been taking medication for Alzheimer's disease (such as cholinesterase inhibitors or memantine) for at least the past month
  • People who are able to walk at least 400 metres within 6 minutes, showing a basic level of physical mobility
  • People who are able to read and understand instructions written in Turkish

Who may not be able to join:

  • People who have a different type of dementia, such as Lewy body dementia or frontotemporal dementia
  • People who have been regularly following a structured exercise program within the 6 months before the study begins
  • People who have lung, nerve, muscle, joint, or bone conditions that make walking difficult
  • People who have an unstable health condition, such as poorly controlled diabetes, uncontrolled high blood pressure, or blood clots in the veins
  • People who have significant vision or hearing difficulties that make communication hard
  • People who have behavioural difficulties that would make taking part in exercise sessions difficult

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +90 216 547 26 00

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul University - Cerrahpasa
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 December 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Timed Up and Go Test; Trail Making Test; Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov